Aniling has attended “The Cell-NCI Symposium: Beyond Cancer Genomics Toward Precision Oncology” organized by the
Cell Press and the National Cancer Institute (NCI).
Sheila Santín has presented the advances of our first product, GEUS-CLL, an IVD test for the diagnosis, prognosis and treatment selection for chronic lymphocytic leukemia (CLL). In parallel, Marta Forn Bernaus has been showing the advances of our new colorectal cancer IVD test, GEUS-CRC. We have enjoyed outstanding talks and lots of exciting discussions.